L. Roy Papp & Associates LLP trimmed its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.4% during the 2nd quarter, HoldingsChannel reports. The fund owned 13,981 shares of the company’s stock after selling 1,453 shares during the quarter. L. Roy Papp & Associates LLP’s holdings in Clorox were worth $1,679,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently added to or reduced their stakes in CLX. Park Avenue Securities LLC acquired a new stake in Clorox during the first quarter valued at approximately $258,000. Farther Finance Advisors LLC boosted its holdings in Clorox by 25.4% during the first quarter. Farther Finance Advisors LLC now owns 5,872 shares of the company’s stock valued at $869,000 after purchasing an additional 1,190 shares in the last quarter. Pallas Capital Advisors LLC acquired a new stake in Clorox during the first quarter valued at approximately $647,000. Wealthcare Advisory Partners LLC boosted its holdings in Clorox by 47.8% during the first quarter. Wealthcare Advisory Partners LLC now owns 2,350 shares of the company’s stock valued at $346,000 after purchasing an additional 760 shares in the last quarter. Finally, Simplicity Wealth LLC acquired a new stake in Clorox during the first quarter valued at approximately $1,048,000. 78.53% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on the company. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Jefferies Financial Group decreased their price objective on Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. TD Cowen reduced their target price on Clorox from $120.00 to $117.00 and set a “hold” rating on the stock in a report on Wednesday, October 1st. Bank of America reduced their target price on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. boosted their target price on Clorox from $133.00 to $135.00 and gave the stock a “neutral” rating in a report on Monday, September 8th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $132.54.
Insider Transactions at Clorox
In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.57% of the company’s stock.
Clorox Stock Up 0.3%
NYSE:CLX opened at $119.98 on Friday. The stock’s fifty day moving average price is $122.27 and its two-hundred day moving average price is $128.94. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a market cap of $14.67 billion, a price-to-earnings ratio of 18.40, a P/E/G ratio of 0.98 and a beta of 0.52.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same quarter in the prior year, the business earned $1.82 EPS. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.1%. Clorox’s dividend payout ratio is currently 76.07%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- What Are Dividend Champions? How to Invest in the Champions
- Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
- Election Stocks: How Elections Affect the Stock Market
- Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
- When to Sell a Stock for Profit or Loss
- Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
